The significance of human papillomavirus infection detected by cervical cytology among women infected with the human immunodeficiency virus

Journal of Obstetrics and Gynaecology

Volumn 24, Issue 8, 2004, Pages 903-906

  Moodley, M ^a   Garib, R ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; UTERINE CERVIX EPITHELIUM; VIRUS INFECTION; WART VIRUS;

ADULT; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; VAGINAL SMEARS;

EID: 22344450079     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610400018908     Document Type: Article

References (23)

1. Branca M., Rossi E., Alderisio M., Migliore G., Morosini P.L., Vecchione A. and Sopracordevole F. (2001) Performance of cytology and colposcopy in diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-positive and HIV-negative women. Cytopathology, 12, 84-93.
2. Carlucci M., Cimmino A., Fiore M.G., Lepera A., Tantimonaco L. and Ricco R. (2001) The Pap test in HIV-positive women. Pathologica, 93, 651-653.
3. Centers for Disease Control (CDC) (1998) Guidelines for the treatment of sexually transmitted diseases. Morbidity and Mortality Weekly Review, 47, 1-111.
4. Conley L.J., Ellerbrock T.V., Bush T.J., Chiasson M.A., Sawo D. and Wright T.C. (2002) HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet, 359, 108-113.
5. Dolei A., Curreli S., Marongiu P., Pierangeli A., Gomes E., Bucci M., Serra C. and Degener A.M. (1999) Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein. Journal of General Virology, 80, 2937-2944.
6. Dorrington R.E., Bradshaw D. and Budlender D. (2002) HIV/AIDS profile of the provinces of South Africa - indicators for 2002. Centre for Actuarial Research, Medical Research Council and the Actuarial Society of South Africa, 2-5.
7. Duerr A., Kieke B., Warren D., Shah K., Burk R., Piepert J.F., Schuman P. and Khan R.S. (2001) Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. American Journal of Obstetrics and Gynecology, 184, 584-590.
8. Ellerbrock T.V., Chiasson M.A., Bush T.J., Sun X.W., Sawo D., Brudney K. and Wright T.C. (2000) Incidence of cervical squamous intraepithelial lesions in HIV-infected women. Journal of the American Medical Association, 283, 1031-1037.
9. Ferenczy A., Coutlee F., Franco E. and Hankins C. (2003) Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. Canadian Medical Association Journal, 169, 431-434.
10. Goodman A., Chaudhuri P.M., Tobin-Enos N.J. and Hutchinson M.L. (2000) The false negative rate of cervical smears in high risk HIV seropositive and seronegative women. International Journal of Gynecological Cancer, 10, 27-32.
11. Holcomb K., Abulafia O., Matthews R.P., Chapman J.E., Borges A., Lee Y.C. and Buhl A. (1999) The significance of ASCUS cytology in HIV positive women. Gynecologic Oncology, 75, 118-121.
12. Koss L. (1989) The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. Journal of the American Medical Association, 261, 737-743.
13. Kuhn L., Sun X.-W. and Wright T.C. (1999) Human immunodeficiency virus infection and female lower genital tract malignancy. Current Opinion in Obstetrics and Gynecology, 11, 35-39.
14. Levi J.E., Fink M.C., Canto C.L., Carretiero N., Matsubara R., Linhares I. and Das Dores G.B. (2002) Human papillomavirus prevalence, viral load and cervical intra-epithelial neoplasia in HIV infected women. Brazilian Journal of Infectious Diseases, 6, 129-135.
15. Maiman M., Fruchter R.G., Sedlis A., Feldman J., Chen P., Burk R.D. and Minkoff H.H. (1998) Prevalence, risk factors and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with human immunodeficiency virus. Gynecologic Oncology, 68, 233-239.
16. Maiman M., Tarricone N., Vieira J., Suarez J., Serur E. and Boyce J.G. (1991) Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstetrics and Gynecology, 78, 84-88.
17. Moodley M., Moodley J. and Kleinschmidt I. (2001) Invasive cervical cancer and human immunodeficiency virus infection: a South African perspective. International Journal of Gynecological Cancer, 11, 194-197.
18. Palefsky J.M., Minkoff H., Kalish L.A., Levine A., Sacks H.S., Garcia P. and Young M. (1999) Cervicovaginal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Journal of the National Cancer Institute, 91, 226-236.
19. Robinson W.R., Luck M.B., Kendall M.A. and Darragh T.M. (2003) The predictive value of cytologic testing in women with the human immunodeficiency virus who have low-grade squamous cervical lesions: a substudy of a randomized, phase III chemopreventative trial. American Journal of Obstetrics and Gynecology, 188, 896-900.
20. Spitzer M. (1998) Cervical screening adjuncts: recent advances. American Journal of Obstetrics and Gynecology, 179, 544-546.
21. Sun X.W., Ellerbrock T.V., Lungu O., Chiasson M.A., Bush T.J. and Wright T.C. Jr. (1995) Human papillomavirus virus infection in human immunodeficiency virus-seropositive women. Obstetrics and Gynecology, 85, 680-686.
22. Wright T.C. and Sun X.-W. (1996) Anogenital papillomavirus infection and neoplasia in immunodeficient women. Obstetrics and Gynecology Clinics of North America, 23, 861-894.
23. Wright T.C., Ellerbrock T.V., Chiasson M.A., Van Devanter N. and Sun X.W. (1994) Cervical intraepithelial neoplasia in women infected with human immunodeficiencey virus: prevalence, risk factors and validity of Papanicolaou smears. Obstetrics and Gynecology, 84, 591-597.